Biotech investors are always looking for companies developing new therapies for tough-to-treat diseases like cancer, but that growth focus almost always puts them at odds with dividend investors, who are more interested in steady and stable growth.
Finding biotech investments that fit the needs of both growth and dividend investors is no easy job. But there are three intriguing companies with ties to biotech that do pay dividends. In the following slide showshow, you'll learn how Amgen (AMGN 11.82%), PDL Biopharma (PDLI), and Teva Pharmaceuticals (TEVA -0.71%) are leveraging biologics for dividend-friendly cash flow.
